全文获取类型
收费全文 | 7666篇 |
免费 | 662篇 |
国内免费 | 4篇 |
出版年
2023年 | 54篇 |
2022年 | 124篇 |
2021年 | 274篇 |
2020年 | 149篇 |
2019年 | 178篇 |
2018年 | 200篇 |
2017年 | 161篇 |
2016年 | 336篇 |
2015年 | 510篇 |
2014年 | 526篇 |
2013年 | 535篇 |
2012年 | 764篇 |
2011年 | 654篇 |
2010年 | 380篇 |
2009年 | 368篇 |
2008年 | 493篇 |
2007年 | 425篇 |
2006年 | 380篇 |
2005年 | 295篇 |
2004年 | 292篇 |
2003年 | 267篇 |
2002年 | 243篇 |
2001年 | 54篇 |
2000年 | 33篇 |
1999年 | 41篇 |
1998年 | 60篇 |
1997年 | 30篇 |
1996年 | 22篇 |
1995年 | 27篇 |
1994年 | 23篇 |
1993年 | 27篇 |
1992年 | 24篇 |
1991年 | 22篇 |
1990年 | 18篇 |
1989年 | 21篇 |
1988年 | 15篇 |
1987年 | 12篇 |
1986年 | 12篇 |
1985年 | 18篇 |
1984年 | 18篇 |
1983年 | 25篇 |
1982年 | 10篇 |
1981年 | 18篇 |
1980年 | 15篇 |
1979年 | 13篇 |
1978年 | 16篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1975年 | 11篇 |
1974年 | 10篇 |
排序方式: 共有8332条查询结果,搜索用时 203 毫秒
71.
L. T. Hilliard 《BMJ (Clinical research ed.)》1954,1(4875):1372-1374
72.
73.
74.
75.
76.
77.
78.
Yuejia Dang Yi Wei Yanyan Wang Shaoshuai Liu Chekanova Julia Shi-Hong Zhang 《Environmental microbiology》2021,23(9):4881-4895
ATP-dependent Lon proteases function in bacterial pathogenesis by regulating the expression of the Type III secretion system; however, little is known about how Lon proteases regulate fungal pathogenesis. We previously investigated Lon-binding proteins involved in fungal pathogenesis that interact with PrePL, the smallest Magnaporthe oryzae Lon-binding protein. Here, we show that Lon cleaves PrePL and produces Pc, an extracellular 11-kDa isoform with catalase and peroxidase activity. The ΔPrePL loss-of-function strain showed stronger sporulation and accelerated disease development, suggesting a temporally specific negative regulatory mechanism controlled by PrePL in disease progression. Neither the truncated Pc, nor the full-length PrePL missing the Lon cleavage site complemented the ΔPrePL phenotype, suggesting that full-length PrePL and Pc both function in fungal development. PrePL targeted to the mitochondria undergoes hydrolysis by Lon to produce Pc, which accumulates in the fungal apoplast. Importantly, recombinant Pc induced plant defence responses and cell death after being infiltrated into selected plant leaves, indicating that it functions as an avirulence factor. This work thus reveals a novel pathogenic factor in the fungal Lon-mediated pathway. Additionally, our results provide new insight into the functions of a full-length protein and its cleaved isoform in fungal pathogenesis. 相似文献
79.
Laura Stanbery Nisha J D'Silva Julia S Lee Carol R Bradford Thomas E Carey Mark E Prince Gregory T Wolf Francis P Worden Kitrina G Cordell Elizabeth M Petty 《Translational oncology》2010,3(4):239-245
The purpose of this work was to determine SEPT9_v1 expression levels in head and neck squamous cell carcinoma (HNSCC) and to analyze whether SEPT9_v1 expression is relevant to clinical outcomes. Recently, the SEPT9 isoform SEPT9_v1 has been implicated in oncogenesis, and methylation of the SEPT9 promoter region was reported in HNSCC. These findings led us to hypothesize that SEPT9_v1 could be differently expressed in HNSCC. To determine whether SEPT9_v1 is expressed in HNSCC, tissue microarray immunohistochemical analysis was performed using a SEPT9_v1-specific antibody. Tissue microarrays stained with a polyclonal SEPT9_v1-specific antibody was used to determine protein expression levels in HNSCC tissue samples, some with known clinical outcomes. This analysis showed that SEPT9_v1 is in fact highly expressed in HNSCC compared with normal epithelium, and high expression levels directly correlated with poor clinical outcomes. Specifically, a high SEPT9_v1 expression was associated with decreased disease-specific survival (P = .012), time to indication of surgery at primary site (P = .008), response to induction chemotherapy (P = .0002), and response to chemotherapy (P = .02), as well as advanced tumor stage (P = .012) and N stage (P = .0014). The expression of SEPT9_v1 was also strongly correlated with smoking status (P = .00094). SEPT9_v1 is highly expressed in HNSCC, and a high expression of SEPT9_v1 is associated with poor clinical outcomes. These data indicate that SEPT9_v1 warrants additional investigation as a potential biomarker for HNSCC. 相似文献
80.